Summary
Following thymic output, ab þ CD4 þ T cells become activated in the periphery when they encounter peptide-major histocompatibility complex. A combination of cytokine and co-stimulatory signals instructs the differentiation of T cells into various lineages and subsequent expansion and contraction during an appropriate and protective immune response. Our understanding of the events leading to Tcell lineage commitment has been dominated by a single fate model describing the commitment of T cells to one of several helper (T H ), follicular helper (T FH ) or regulatory (T REG ) phenotypes. Although a single lineage-committed and dedicated T cell may best execute a single function, the view of a single fate for T cells has recently been challenged. A relatively new paradigm in ab þ CD4 þ T-cell biology indicates that T cells are much more flexible than previously appreciated, with the ability to change between helper phenotypes, between helper and follicular helper, or, most extremely, between helper and regulatory functions. In this review, we comprehensively summarize the recent literature identifying when T H or T REG cell plasticity occurs, provide potential mechanisms of plasticity and ask if T-cell plasticity is beneficial or detrimental to immunity.
Introduction: T-cell differentiation programmes
The differentiation of ab þ CD4 þ T cells is the result of combined T-cell receptor (TCR) engagement, co-stimulation and distinct cytokine receptor ligation. These three signals, sequential or concurrent, activate and phosphorylate a suite of transcription factors (TFs) that translocate into the nucleus. TFs binding to cis-regulatory elements (promoters, enhancers, insulators and silencers) within gene promoter regions translate extracellular signals to downstream transcriptional programmes. Epigenetic changes to cis-regulatory elements can influence TF binding and the subsequent fate of the cell, adding a level of regulation at this early stage of cell differentiation. Target gene transcription and translation convert naive T cells into mature T cells with distinguishable features, including the expression of specific adhesion molecules and surface receptors, chemokine-producing capacity and activation of often distinguishable metabolic pathways [1] . Differentiated T helper (T H ) cells can be defined and distinguished from one another by their primary cytokine-producing capacity, including, but not limited to, interferon (IFN)g-producing T H 1 cells, interleukin (IL)-4-producing T H 2 cells, IL-17A-producing T H 17 cells and IL-9-secreting T H 9 cells. Mature T H cells function to mobilize and activate innate cells, re-enforce T H cell commitment and orchestrate local tissue responses through various lymphokine secretions [2] . In addition to a helper fate for T cells, naive ab including Foxp3 þ natural T REG (nT REG ), which develop in the thymus in response to self-antigen [3] , and inducible Foxp3 þ (iT REG ) cells, which develop in the periphery in response to exogenous antigen and transforming growth factor (TGF)-b [4] . Non-Foxp3-expressing T REG cells have also been identified, including TGF-b-secreting (T H 3) [5] , IL-10-secreting (T R 1) [6] or IL-35-secreting (T R 35) T REG [7] cells; however, in this review, we will focus on Foxp3 þ T REG cells.
The transcriptional programmes, mediated by a suite of TFs and signal transducer and activator of transcription (STAT) molecules, for the differentiation of T H , T FH or T REG cells are mostly well defined. For example, Tbet, STAT-1 and STAT-4 are required for T H 1 differentiation, GATA-3 and STAT-5 for T H 2, RORgt and STAT-3 for T H 17, PU-1 for T H 9 [8] , BCL6 for T FH [9] and Foxp3 and STAT-5 for nT REG and iT REG cells. Although Bcl6 and PU-1 are necessary for T FH [9] and T H 9 [8] cell differentiation, respectively, they are not sufficient to coordinate the full transcriptional programme, suggesting that other, or additional transcriptional regulators are required. The TF Foxp3 appears to be restricted to T REG cells [10] and is essential for the development, maintenance and function of T REG cells [11] [12] [13] . Deficiency in Foxp3 can lead to severe immunopathology with multi-organ lymphoproliferative autoimmune disease identified in spontaneous mutant scurfy mice and in rare cases in humans, known as IPEX syndrome (immune dysregulation, polyendocrinopathy, enteropathy, X-linked). For these reasons, Foxp3 has been considered as a master regulator of T REG cell development and function, and is often used as a marker of T REG cells. However, evidence is emerging that Foxp3 alone is not sufficient to regulate the T REG cell phenotype. A combination of computational network inference and proteomics has characterized the highly regulated transcriptional network of co-factors interacting with Foxp3 that are required for T REG cell differentiation [14, 15] . Additionally, analysis of genome-wide binding sites and DNAse I sites revealed Foxp3 functions through pre-existing enhancers already bound by co-factors [16] , and requires the establishment of a CPG hypomethylation pattern at the Foxp3 binding site [17] . As discussed by others [18] , these studies highlight the complexity of signals required for T-cell differentiation, perpetuating the question of adaptation of T REG cells.
Until recently, the doctrine that ab þ CD4 þ T cells were restricted to a particular fate (including T H 1, T H 2, T H 9, T H 17, T FH or T REG ; figure 1) was widely, but not completely, accepted. While the single-fate model is useful, it is often based on in vitro studies, often using supra-physiological stimulation, mitogens, phorbol esters and calcium ionophores or high levels of antigen. Recent studies challenging the single-fate model have highlighted a significant degree of flexibility and plasticity between T-cell destinies in vitro and to a lesser extent in vivo. In this review, we summarize the recent literature reporting T-cell plasticity within and between T H , T FH and T REG cells, describe the current proposed mechanisms, and finally ask whether plasticity within ab þ CD4 þ T cells is beneficial or detrimental to immunity.
3. The changing profile of helper T cells
T H 17/T H 1 conversion
Since the identification of IL-17A-secreting T H 17 cells almost a decade ago [19] and the later discovery of the signals required for their development [20, 21] , T H 17 cells have been found to be relatively unstable [22, 23] , with IL-4 [24] , IFNg [25, 26] , high-dose TGF-b [21] , IL-2 [27] and IL-27 [28] all capable of inhibiting or suppressing T H 17 cell differentiation (figure 2). In vitro and ex vivo from mice [29, 30] and humans [31] , IFNg and IL-17A co-producing cells were evident, but largely ignored. Addressing this phenomenon in more detail, Lee et al. [32] , and later Mukasa et al. [33] In vitro-or ex vivo-derived T H 17 cells, sorted by fluorescence activated cell sorting using an IL-17A cytokine secretion assay, could produce IL-4 upon secondary culture in T H 2 conditions, or upon transfer into helminth-infected mice [40] , suggesting that IL-4-sensitive T H 17 cells can actively convert into IL-4-secreting T H 2 cells. A separate study suggested that T H 17 cells were more rigid, with IL-17A-producing T cells isolated ex vivo refractory to T H 2 conversion when re-stimulated with IL-4 [36] . Whether the stage or maturity of T H 17 differentiation, as suggested above [41] , antigen exposure and specificity or receptor expression distinguishes these studies was unclear from the reports. The hypothesis that T H 17 cells can convert to T H 2 cells is further supported by in vivo observations, mainly in the context of lung inflammation [42, 43] . IL-13 þ IL- [42] . In vitro observations also support the notion that T H 17 cells can be re-programmed into T H 2 cells, but not vice versa [36] . The transcriptional repressor growth factor independent 1 (Gfi-1) can partially explain the lack of T H 2 to T H 17 conversion. Gfi-1 is induced by IL-4, stabilizing T H 2 cells. However, Gfi-1-deficient T H 2 cells were able to produce IL-17A in secondary T H 17 culture conditions [44] . Hegazy et al. [53] Lee et al. [32] Bending et al. [22] Lohning et al. [52] Hegazy et al. [53] Lexberg et al. [36] Cosmi et al. [43] Wang et al.
[45] Cosmi et al. [43] Hirota et al. [35] Lee et al. [32] Mukasa et al. [33] in 
T H 1/T H 2 conversion
The relationship between T H 1 and T H 2 cells has been the subject of a vast amount of research. Notably, there is much evidence to suggest that T H 1 and T H 2 cells cross-regulate one another (figure 2). For example, in vitro studies show that T H 2-associated GATA-3 inhibits T H 1-related IFNg [46] and T H 1-associated Tbet inhibits T H 2-related GATA-3 [47] . It has also been demonstrated that after repeated rounds of stimulation in vitro, T H 1 and T H 2 cells lose their ability to interconvert [41] ; that is, T H 1 and T H 2 cells are less plastic following more rounds of cell division [48] . One simple explanation for this is the downregulation of IL-12Rb expression on T H 2 cells that was shown in vitro [49] , rendering T H 2 cells un-responsive to lL-12; however, this has been later challenged [50] . Furthermore, in vitro cells may be substantially different from in vivo cells, as IFNg þ IL-4 þ cells can be readily observed in vivo in mice [51] . As a proof-of-principle using murine transgenic TCR-restricted T cells, in vitro-polarized, lymphocytic choriomeningitis virus (LCMV)-specific T H 1 or T H 2 cells could give rise to comparable frequencies of IFNg-producing cells following LCMV infection. Interestingly, the T H 2-polarized cells gave rise to a substantial population of cells coexpressing IL-4 and IFNg [52] . The conversion of LCMVspecific T H 2 cells required TCR stimulation as well as the presence of type I and type II interferons [53] . The authors also report a substantial population of IFNg-producing cells developing from in vitro-derived T H 2 cells when cultured in secondary conditions containing IL-12, IFNg and IFNa/b [53] . In these studies, it is possible that not all adoptively transferred in vitro T H 2 cells were fully committed T H 2 cells and that TCR-restricted T cells do not reflect natural polyclonal T-cell populations. Nevertheless, these data not only highlight the ability of T H 2 cells to become IFNg-secreting cells, but also highlight that factors present in vivo, which are not common constituents of in vitro culture systems, such as type 1 interferons, can clearly contribute to T H plasticity.
IL-9-secreting T cells (T H 9)
In addition to the ability of T H 2 cells to co-express IFNg, two reports independently identified the secretion of IL-9 from T H 2 cells and suggested that T H 2 cells could be re-programmed to produce IL-9. These reports led to the classification of T H 9 cells. These initial studies used IL-4 gfp reporter mice to generate T H 2 cells in vitro and subsequently identified that TGF-b provided an essential conversion signal to IL-4 gfpþ cells. 'Ex-T H 2' cells downregulated classical T H 2 genes (Gata3 and Il4) and upregulated IL-9 [54, 55] . The T H 2 heritage of IL-9-secreting cells is supported by their requirement for STAT-6 [56, 57] and the observation of IL-9-producing T cells in T H 2-associated allergic inflammation [58] [59] [60] . However, T H 9 cells have also been identified in autoimmunity [61] and more recently in Mycobacterium tuberculosis infection [62] , more commonly associated with T H 1/T H 17 responses. Whether IL-9-secreting cells are indeed a distinct lineage [63] , warranting a 'T H ' prefix, or simply recently activated T H , as suggested by others [64] , or T REG cells [65] remains to be clarified. Candidates for a T H 9 'master regulator' have been suggested, however, including PU-1 [8] . Thus, whether IL-9 secretion by T H 1, T H 2, T H 17 or T REG cells constitutes T-cell plasticity or not is unclear at present. In summary, the ability of T H 1, T H 2 or T H 17 cells to coexpress IFNg, IL-4, IL-17A or IL-9 can be demonstrated in vitro and in more restricted and occasionally contrived situations in vivo. Interestingly, these phenomena have most frequently been observed during hyper-inflammatory disorders, such as autoimmune or allergic pathologies, with the exception of the LCMV studies [52, 53] . There is little evidence that T H plasticity is beneficial during immunity to infection, and it could be hypothesized that the occurrence of plasticity contributes to the development of inflammatory disorders.
The changing profile and nature of regulatory T cells
The stability of Foxp3 þ T REG cells has been, and continues to be, enthusiastically debated, especially as T REG -based therapies move closer to the clinic [66] [67] [68] . Two novel areas of T REG cell biology, T REG specialization and T REG instability, are fuelling the debate on T REG plasticity. In an attempt to reconcile the debate, Miyao et al. [69] 
T REG instability: conversion to T effector phenotypes

T REG /T H 1 conversion
The relationship between T H 1 and T REG was first described in a study that identified a population of OVA-specific T H 1-related Foxp3 þ T REG , which produced IL-10 and IFNg, or pro-inflammatory cytokines IL-1b, IL-6, IL-2, IL-21 and IL-23 have also been identified in the peripheral blood [103] and tonsils [104] of healthy donors. These cells were also able to suppress CD4 þ T cells via cell contact-dependent mechanisms.
T REG /T H 17 conversion
Given the close developmental relationship between iT REG and T H 17 cells [95] and the intimate cross-regulation by RORgt and
Foxp3, the conversion between T H 17 and T REG cells may not be too surprising. However, the opposing function of these cell types would require tightly regulated mechanisms, critical to preventing regulators of autoimmunity converting into effectors. Whether a breakdown in these regulatory pathways, such as the IDO/IL-6 pathway described above [100] , underpins the development of autoreactivity, in addition to tumour immunosurveillance, is unclear.
T REG /T H 2 conversion
The ability of T REG cells to convert into IL-4-secreting T H 2 cells has also been reported. The Foxp3 
T REG /T FH conversion
Potential mechanisms of T-cell plasticity
From the studies mentioned above, the ability of CD4 þ T cells to change their phenotype is clear. Whether there is progression from a less stable to a more stable state, as suggested by others [110] , or whether the T-cell phenotype is simply a reflection of the transient micro-environment has yet to be determined. Although not directly tested in any of the studies mentioned throughout this review, whether the genetic background of mice used contributes to plasticity or not is unclear and yet to be tested. With the advent of well-defined genetic tools, such as the international Collaborative Cross [111] , dissecting genetic determinants of T-cell responsiveness will now be much easier. However, to date, several mechanisms that influence T-cell plasticity have been proposed, generally separable into extrinsic and intrinsic pathways (see figure 4 ).
Cell extrinsic mechanisms of T-cell conversion
Accessory innate cells and innate receptors
Although often bypassed using in vitro T-cell assays, antigenpresenting cells (APCs) displaying various co-stimulatory molecules on their surface translate innate antigen recognition signals into the appropriate instructions for T cells. It has been well documented that high antigen doses, and higher affinity peptides, polarize responding naive T cells into T H 1 cells, while low antigen doses, and lower affinity peptides, favour T H 2 polarization [112, 113] . It is therefore conceivable that the T H cell response may transition from a pro-inflammatory T H 1-, and possibly T H 17-, dominant phenotype during antigen abundance, or high pathogen load in the case of infection, when cells are also potentially refractory to T REGmediated suppression [114] , into a T H 2 phenotype as the antigen is reduced. Beyond TCR-major histocompatibility complex II-peptide interactions, co-stimulatory molecules on APCs, particularly the B7 family members, which greatly influence T-cell differentiation [112, 115, 116] , may also have the potential to transform and re-polarize differentiated T H cells by modulating cytokine responsiveness [117] . [120] . However, in vivo experiments highlighted the requirement of TLR4 ligation for T H 1 and T H 17-mediated disease. Disruption of TLR signalling, by deleting the essential downstream adaptor MyD88 in T cells, compromised protective T H 1-mediated immunity to T. gondii [121] . Using an EAE model and TLR4 [120] or TLR2-deficient [122] CD4 T cells, T H 17 and T H 1-dependent disease was also significantly abrogated. Further support for TLR4 signalling in T cells has been reported in a model of colitis [123] , where TLR4/IL-10-deficient T cells were more pathogenic, compared with IL-10-deficent cells. Although the extent of TLR signalling on T-cell stability and plasticity has not been reported, given the requirement for TLR4-mediated signals for T H 17 and T H 1 responses, TLR signalling could be an influential trigger in T-cell phenotype decisions.
Other innate cells, including IL-4-secreting basophils, neutrophils in various stages of apoptosis and inducible nitric oxide-producing macrophages, can promote T H 2 [124, 125] , T H 17 [126] or T H 1 [127] differentiation, respectively, and may also contribute to T-cell plasticity. Finally, the emerging field of innate-like helper cells (ILCs), which appear to mirror T H cell subsets [128] , can influence naive T-cell differentiation [129] , and potentially differentiate T cells promoting plasticity. The high levels of IFNg, IL-17A and IL-22 or IL-5 and IL-13 secreted by the three main populations of ILCs have the potential to deviate T-cell and non-T-cell responses.
Cytokine micro-environment and cytokine receptor regulation
The cytokine micro-environment can activate, inhibit and directly modify differentiated T H cells. rsob.royalsocietypublishing.org Open Biol 3: 120157
and IL-18 [132] has long been appreciated in the differentiation of T H 1 and T H 2 cells [49] . Initial studies demonstrated that T H 2 cells downregulate IL-12R, leaving cells refractory to IL-12, while T H 1 cells operate positive re-enforcement with IFNgmediated STAT-1 activating Tbet and up-regulating IL-12R expression [133] . In our unpublished observations, and reported by others [50] 
Nutrient availability and metabolic pathways
Throughout T-cell development, differentiation and function, metabolic needs are intimately linked [1] . Following activation, helper T cells rapidly upregulate glucose uptake and glycolysis [143, 144] . In contrast, regulatory T cells upregulate lipid oxidative metabolism [145] , with less glucose uptake and glycolysis. Inhibition of either of these pathways prevents activation, proliferation, cytokine secretion and cellular function [146] . Furthermore, the metabolic needs and pathways of different T H cells diverge, providing another environmental cue that may influence T H cell phenotype switching. For example, distinct phosphoinositide 3-kinase/ mammalian target of rapamycin (mTOR) pathways [147] , via two mTOR complexes, mTORC1 or mTORC2, are employed by T H 1 and T H 17 or T H 2 cells, respectively [148] . Additionally, small concentrations of the small molecule halofuginone, which induces an amino acid starvation response, can limit T H 17 but not T H 1, T H 2 or iT REG polarization in vitro [149] . Hypoxia-induced factor (HIF)1a and cMyc, two TFs that regulate glycolysis [150] , can also modulate the balance between T H 17 and T REG differentiation by controlling glycolytic metabolism [151] . Concordantly, mice with HIF1a-deficient T cells, with subsequently compromised glycolysis, have increased T REG cells and are protected from T-cell-mediated autoimmunity [152] . Thus, at the simplest level, shuttling between glycolysis and lipid oxidation pathways can favour T-cell differentiation pathways between T H and T REG cells. It is clear that the T cells have specific metabolic requirements and that these requirements differ between T H and T REG subsets; it is yet undetermined whether these metabolic pathways are important for T-cell plasticity in vivo. 
Epigenetic modifications
Recent studies have combined gene expression profiling with ChIP-Seq and high-throughput sequencing to investigate the chromatin state in resting and effector T cells [167, 168] . These studies have revealed important insights into the mechanisms of T-cell plasticity and stability. For example, the proximal promoter of Ifng has permissive methylation marks in T H 1 cells, but repressive marks in T H 2 and T H 17 cells, indicating that specific effector functions may be regulated through epigenetics. Interestingly, in various T H cells, bivalent marks allowing enhancement or repression were found at TF genes, including bivalent marks at Tbet and Gata3 in T H 17 cells, at Gata3 in T H 1 cells, at Tbet in T H 2 cells, and at Tbet, Gata3, and Rorc in T REG cells. This suggests the potential for substantial reversibility at the TF level [32, 168] . T H subsets also show positive marks on the Bcl-6 locus, providing the possibility for T H cells to take on a T FH phenotype [169] . In addition, studies using both wild-type and STAT-4 or STAT-6 knockout T cells have revealed that these transcriptional regulators have effects on epigenetic modifications in T cells [170] . Given the bivalent marks at TF genes in T H cells, epigenetic modifications of effector genes, such as Ifng, Il17a or Il5 in T cells may be critical regulators of T-cell effector cytokine production. Although epigenetic modifications influence T H cell gene expression, how epigenetic modifications are regulated in T cells is unclear, and therefore how this mechanism would directly contribute to T-cell plasticity is uncertain.
Multiple overlapping mechanisms may all contribute to T-cell plasticity, including epigenetic modifications, posttranscriptional regulation by miRNAs, changes in metabolic activity and activation of TFs.
9. T-cell plasticity in immunity: beneficial or detrimental?
As suggested by others [171] , the rapid conversion between T REG and T H cell and within T H cell populations could be a very useful feature of the adaptive immune system. Such dexterity could retain antigen-specificity and subsequent memory, preserve the appropriate tropism and rapidly respond to the changing demands and needs of the local environment. With respect to immunity to infection, we have previously reported that increased resistance to the helminth parasite Schistosoma mansoni following drug treatment and IL-10R blockade led to elevated antigen-specific IFNg, IL-5 and IL-17A production [172] . Similarly, lethal infection of IL-10-deficient mice with the intestinal whipworm parasite Trichuris muris led to increased parasite-antigen-induced IFNg and IL-17A [173] . Whether elevated T-cell-derived IFNg and IL-17A secretions were from T H 2 cells (i.e. polyfunctional) or from converted T H 2 cells (i.e. plasticity) is yet to be determined. Also, the precise involvement of IL-10 in regulating these responses was not investigated. In highly regulated environments such as the gut and airways, an effector response must be able to mature in response to infection and overcome local regulatory mechanisms. Indeed, the ability to mount a rapid and lethal T H 1 response following oral T. gondii infection was due to T-cell plasticity, where Foxp3 þ cells converted into pathogenic IFNg-secreting cells [91] . If plasticity contributed to the observed phenotypes following S. mansoni, T. muris and T. gondii infection, then despite providing superior pathogen control, significant immunopathology developed. However, the plasticity of T H cells without severe consequences has also been observed in several infection models [40, 51, 53, 153] , indicating that plasticity, when absolutely necessary, can provide T-cellmediated immunity. It remains unclear when plasticity is required to combat infection, under physiological conditions. Studies in infectious disease models, however, provide ideal systems to probe T-cell plasticity throughout induction, expansion and resolution of the T-cell response. Several studies have identified the plasticity of T cells during autoimmunity [22, 35, 94] and allergy [42, 45, 107] . Whether T-cell plasticity contributes to the pathogenesis or resolution of these immunopathologies is too early to tell. Nevertheless, strategies to deviate T-cell responses in allergy are being pursued, as described above [118] .
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Currently, there is limited evidence showing T H plasticity occurring in vivo as part of an effective immune response. Over the coming years, as we move beyond phenomenology, there is a need to ask what proficient T cells do, in addition to what T cells can do when forced in vitro. Similarly, the use of a single primary cytokine for fully differentiated and committed T H cells may have over-simplified the complexity and flexibility of T cells. The differences noted between in vitro and in vivo systems in this review emphasize the importance of understanding the limitations of experimental systems. New and improved technical approaches will be essential in future research, especially with regard to identifying mechanisms of plasticity. It is, as yet, unclear which mechanisms contribute to plasticity and whether there are common triggers of plasticity among experimental systems or even between subsets. Undoubtedly, further research in this area will help us comprehend not just the extreme capabilities of the immune system but how the immune response functions best and how this can be harnessed.
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